Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 3 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S3258Referred to Committee

Aviation Medication Transparency Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-11-20
Introduced
5
Cosponsors
S
ⓘ
Type

Sponsor

Tammy Duckworth
Tammy Duckworth
Democrat · IL · Senator
Votes with party: 85.8% (830 recorded votes)

Full profile: /officials/D000622

Source: Congress.gov · FEC

Cosponsors (5)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • John Hoeven (R-ND)Original· 2025-11-20
  • Katie Boyd Britt (R-AL)Original· 2025-11-20
  • Richard J. Durbin (D-IL)Original· 2025-11-20
  • James E. Risch (R-ID)· 2026-02-10
  • John W. Hickenlooper (D-CO)· 2026-02-10

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.

2026-07-22

Source: Congress.gov

Committee Activity

Currently in

  • Senate Committee on Commerce, Science, and TransportationMarkup By · 2026-07-22

Previously

  • Senate Committee on Commerce, Science, and TransportationReferred To · 2025-11-20

Plain-English Summary

Aviation Medication Transparency Act of 2025 This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification. Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications.

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Transportation and Public Works

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3258 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 3258 To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES November 20, 2025 Ms. Duckworth (for herself, Mr. Hoeven, Mr. Durbin, and Mrs. Britt) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation _______________________________________________________________________ A BILL To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Aviation Medication Transparency Act of 2025''. SEC. 2. AVIATION MEDICATION TRANSPARENCY; LIST OF APPROVED MEDICATIONS. (a) Purpose.--The purpose of this Act is to ensure that aviation stakeholders, including airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists, who are applicants for medical certification are informed, in a user-friendly and accessible manner, of the medications they may be safely prescribed. (b) In General.--Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration (in this section referred to as the ``Administrator'') shall publish and maintain on a publicly available website of the Federal Aviation Administration (in this section referred to as the ``FAA'') a list of medications that the Administrator, as of the date of publication, has-- (1) determined may be safely prescribed to an applicant for medical certification to treat certain medical conditions; and (2) approved for purposes of the issuance of a medical certification to an airman or air traffic control specialist. (c) Requirements.--To ensure medical appropriateness, user- friendliness, and appropriate dissemination, the list required under subsection (b) shall-- (1) be drafted in consultation with-- (A) the Aeromedical Innovation and Modernization Working Group (established under section 411(a) of the FAA Reauthorization Act of 2024 (49 U.S.C. 44703 note)) (in this section referred to as the ``Working Group''); (B) institutions of higher education that are accredited by the Aviation Accreditation Board International; (C) the certified exclusive bargaining representatives of air traffic controllers of the FAA certified under section 7111 of title 5, United States Code; (D) organizations representing certified collective bargaining representative of airline pilots; and (E) any other stakeholder determined relevant by the Working Group; (2) cover all medications approved by the Administrator, including prescription medications and over-the-counter medications; (3) be drafted in a user-friendly and accessible manner and provided to airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists at the time when any such individual first seeks a medical certification; (4) if applicable, indicate the minimum and average period of time an airman or air traffic control specialist is required to have limited or no duties to stabilize on an approved medication; (5) include the list of medications that the Administrator has designated as ``Do Not Issue''; (6) include information for doctors or medical providers to contact the FAA regarding questions related to such list, including through a new or existing mechanism that is accessible to such doctors and medical providers; (7) include any additional information that the Administrator determines is appropriate to provide…
Show the remaining 77 wordsHide the remaining 77 words
with respect to what conditions a certain medication may or may not be used to treat, as well as any information to explain why a medication is allowed or prohibited by the FAA; and (8) include any other information or clarification that the Administrator determines appropriate. (d) Annual Update.--Not later than 1 year after the date of publication of the list required under subsection (b), and annually thereafter, the Administrator shall update such list, as appropriate. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • S289Youth Poisoning Protection Act
    Passed Senate · 2026-08-10
  • S3373A bill to designate the facility of the United States Postal Service located at 14855 South Van Dyke Road in Plainfield, Illinois, as the "Staff Sergeant Jose Duenez Jr. Post Office Building".
    Referred to Committee · 2026-08-06
  • S5300Honoring the Sacrifice of Troops in War Act of 2026
    Referred to Committee · 2026-08-06
  • S5171Children's Artificial Intelligence Toy Safety Act of 2026
    Referred to Committee · 2026-08-05